Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
Por um escritor misterioso
Descrição
Prolonged and tunable residence time using reversible covalent kinase inhibitors
PDF] Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. - Abstract - Europe PMC
Sigmoidal correlation between Btk occupancy and experimentally observed
Full article: Drug delivery targets and strategies to address mast cell diseases
Development of covalent inhibitors: Principle, design, and application in cancer - Zheng - 2023 - MedComm – Oncology - Wiley Online Library
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. - Abstract - Europe PMC
Tyrosine Kinase: Most Up-to-Date Encyclopedia, News & Reviews
Frontiers Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia
Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry
Covalent Modifiers: 2017
de
por adulto (o preço varia de acordo com o tamanho do grupo)
